Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 28
Phase 34

Trial Status

Completed9
Terminated1
Other1

Role Distribution

Principal Investigator11
PI Rate100%

Activity Timeline

Clinical Trials (11)

NCT01303861Phase 3Completed
Concurrent Bupropion / Varenicline for Smoking Cessation
Nicotine Dependence
Principalinvestigator
NCT01443858Phase 2Completed
Meclizine as a Potential Smoking Cessation Treatment
Smoking Cessation
Principalinvestigator
NCT01560507Phase 2/3Terminated
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
Cigarette SmokingNicotine Dependence
Principalinvestigator
NCT01806779Phase 2Completed
Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
Nicotine Dependence
Principalinvestigator

Showing 10 of 11 trials

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francis J McClernon, Ph.D.

Duke University

Related
5 trials

Shared therapeutic areas:

Cigarette SmokingNicotine Dependence

Worked with same sponsors:

Duke UniversityNational Institute on Drug Abuse (NIDA)
Collaborated on 1 trial
Similarity Score24%

Mehmet Sofuoglu, M.D.,Ph.D.

Yale University

Related
8 trials

Shared therapeutic areas:

Nicotine DependenceSmoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Nancy A Rigotti, MD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Smoking CessationCigarette Smoking
Similarity Score15%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Nicotine DependenceSmoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Neal L Benowitz, MD

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Cigarette SmokingNicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

A. Eden Evins, MD, MPH

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Smoking CessationNicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Lori Pbert, PhD

University of Massachusetts, Worcester

Related
10 trials

Shared therapeutic areas:

Cigarette SmokingNicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Dorothy Hatsukami, Ph.D.

University of Minnesota

Related
19 trials

Shared therapeutic areas:

Smoking CessationSubstance Withdrawal Syndrome

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Andrew D Krystal, M.D., M.S.

Duke University

Related
1 trials

Shared therapeutic areas:

Nicotine Dependence

Worked with same sponsors:

Duke University
Collaborated on 1 trial
Similarity Score14%

James M Davis, M.D.

Duke University

Related
2 trials

Shared therapeutic areas:

Nicotine Dependence

Worked with same sponsors:

Duke UniversityNational Institute on Drug Abuse (NIDA)
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT00734617Phase 3PrincipalInvestigator

Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II

Cigarette Smoking
Completed
NCT00894166Phase 3PrincipalInvestigator

Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype

Smoking Cessation
Completed
NCT00900900Phase 2PrincipalInvestigator

The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers

Substance Withdrawal Syndrome
Completed
NCT00901459Phase 2PrincipalInvestigator

A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers

Nicotine Dependence
Completed
NCT01303861Phase 3PrincipalInvestigator

Concurrent Bupropion / Varenicline for Smoking Cessation

Nicotine Dependence
Completed
NCT01443858Phase 2PrincipalInvestigator

Meclizine as a Potential Smoking Cessation Treatment

Smoking Cessation
Completed
NCT01560507Phase 2/3PrincipalInvestigator

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Cigarette SmokingNicotine Dependence
Terminated
NCT01806779Phase 2PrincipalInvestigator

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers

Nicotine Dependence
Completed
NCT01857531Phase 2PrincipalInvestigator

Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

Smoking Cessation
Completed
NCT01926626Phase 2PrincipalInvestigator

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

Nicotine Dependence
Completed
NCT02487953Phase 2PrincipalInvestigator

Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment

Nicotine Dependence
Withdrawn

All 11 trials loaded